The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy
The Lance opinion from the Pennsylvania Supreme Court breaks new, negative ground for defendants in drug cases. The Drug and Device blog as usual has a cogent post on the substantive change. The point for note today is that the key states and rulings can and sometimes do reshape tort litigation.
The litigation industry continues to evolve and grow. Consider, for example, this June 19, 2019 press release by a group of firms brining opioid suits, titled: “Lawsuits Filed by Opioid Justice Team
For those litigating drug cases, the NEJM just published an open access article with a broad set of data on medical marketing. It’s online here at NEJM. The abstract is pasted below. ________________
A cogent summary of statutes of repose for drugs and devices is online at a July 16, 2018 guest post at Drug & Device blog.